The authors aimed to determine the maximum tolerated dose (MTD), dose–limiting toxicities (DLT), pharmacokinetics, and biologic effects of cixutumumab administered in combination with temsirolimus to children with refractory solid tumors.

READ FULL ARTICLE Curated publisher From Mdlinx